FRIDAY, APRIL 28 (CONT.) LUNCH BREAK ∙ 12:30 - 1:15 p.m. Theater 3 Discover the Impact of GEMTESA: A Selective B3-Adrenergic Agonist for Effective OAB Treatment Supported by: Sunovion Pharmaceuticals Inc Matt T. Rosenberg, MD ∙ Jackson, MI PM BREAK ∙ 3:45 - 4:30 p.m. Theater 2 Understanding PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets): An Oral Treatment Authorized for COVID-19 Supported by: Pfizer Christian Sandrock, MD, MPH ∙ Sacramento, CA Internal Medicine Meeting 2023 | ONSITE INDUSTRY GUIDE 23http://gotoper.com/internalmed http://gotoper.com/internalmed http://gotoper.com/internalmed http://gotoper.com/internalmed